News

Demodex mites might sound like the ultimate uninvited guests, but for most of us, they’re quiet cohabitants. As long as they don’t get out of control, there’s no need to panic.
Flakes on your scalp making you feel self-conscious? Let’s talk about seborrheic dermatitis vs dandruff. Whether your scalp feels like a snowglobe thanks to dandruff or you’re dealing with red ...
The similarities. Seborrheic dermatitis and psoriasis tend to be lifelong conditions. They can take an emotional toll too, especially when the patches are very noticeable. Both can often be managed.
Aimed at addressing systemic inflammation, National Rosacea Society treatment algorithms take a phenotype-driven approach wherein signs and symptoms guide diagnosis and treatment choices.
Differential Diagnosis The distinctive appearance of POD usually allows it to be distinguished from other inflammatory facial conditions including rosacea, contact dermatitis, acne, and seborrheic ...
Demodex is a type of tiny eight-legged mite that resides in hair follicles and oil glands on our face, chest and neck. This is one of Walter’s voracious vermin. @denverskindoc/TikTok “If you ...
Dear Doctors: I have dandruff, and my doctor says it’s from seborrheic dermatitis. Can you explain what that is? I’ve been using the special shampoo I was given, and it helps. When I stop ...
Dear Doctors: I have dandruff, and my doctor says it’s from seborrheic dermatitis. Can you explain what that is? I’ve been using the special shampoo I was given, and it helps. When I stop ...
Dear Doctors: I have dandruff, and my doctor says it’s from seborrheic dermatitis. Can you explain what that is? I’ve been using the special shampoo I was given, and it helps. When I stop using it, ...
Seborrheic dermatitis is a form of eczema that affects more than 10 million people and causes flakiness, itching, irritation, and in rare instances, hair loss. Here's what you need to know.
Tarsus Pharmaceuticals, Inc.'s Xdemvy, the first FDA-approved treatment for demodex blepharitis, has shown significant efficacy and rapid revenue growth, with $40.8M revenue in Q2 2024.